BNP Paribas Financial Markets’s Ginkgo Bioworks DNA Stock Holding History

BNP Paribas Financial Markets’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	165,281 -7,435	-4%	-$62.2K	﹤0.01%	2959
2026 Q1	$1.06M	Sell	172,716 -2,076	-1%	-$17.3K	﹤0.01%	3099
2025 Q4	$1.45M	Sell	174,792 -10,891	-6%	-$117K	﹤0.01%	2859
2025 Q3	$2.71M	Sell	185,683 -136,443	-42%	-$1.63M	﹤0.01%	2408
2025 Q2	$3.62M	Sell	322,126 -143,031	-31%	-$1.11M	﹤0.01%	2074
2025 Q1	$2.65M	Buy	465,157 +180,046	+63%	+$1.83M	﹤0.01%	2182
2024 Q4	$2.8M	Buy	285,111 +127,249	+81%	+$1.09M	﹤0.01%	2170
2024 Q3	$1.29M	Buy	+157,862	New	+$1.58M	﹤0.01%	2341

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BNP Paribas Financial Markets's DNA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Ginkgo Bioworks (DNA) stake by 4.3% in Q2 2026, selling an estimated $62.2K and leaving 165,281 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

BNP Paribas Financial Markets first reported a position in DNA in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.62M in Q2 2025. 167 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

BNP Paribas Financial Markets held 165,281 shares of Ginkgo Bioworks worth $1.64M as of Q2 2026.
BNP Paribas Financial Markets sold 7,435 Ginkgo Bioworks shares in Q2 2026, an estimated $62.2K.
Ginkgo Bioworks made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2959 holding.
BNP Paribas Financial Markets first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Ginkgo Bioworks position peaked at $3.62M in Q2 2025.
167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.